117.96
0.17 (0.14%)
0.17 (0.14%)
Upgrade to Real-Time
Afterhours (Closed)
Low
79.1101
High
118.67
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AbbVie Inc | ABBV | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.17 | 0.14% | 117.96 | 19:44:51 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 117.78 | 116.76 | 118.30 | 117.96 | 117.79 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 44,956 | 3,760,046 | $ 117.78 | $ 442,847,840 | - | 79.1101 - 118.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:31 | 1 | $ 118.00 | USD |
Period:
Draw Mode:
AbbVie Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 208.34B | 1.77B | 1.76B | $ 45.80B | $ 6.80B | 2.80 | 42.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 4.72 | 4.41% | 07/14/21 | -75.03k | 0.10% |
AbbVie News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABBV Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 115.38 | 118.67 | 115.26 | 117.26 | 4,816,809 | 2.58 | 2.24% |
| 1 Month | 112.65 | 118.67 | 111.61 | 116.31 | 5,728,066 | 5.31 | 4.71% |
| 3 Months | 114.68 | 118.67 | 110.65 | 115.01 | 6,289,481 | 3.28 | 2.86% |
| 6 Months | 106.23 | 118.67 | 101.8117 | 110.33 | 6,815,601 | 11.73 | 11.04% |
| 1 Year | 96.28 | 118.67 | 79.1101 | 102.78 | 7,216,675 | 21.68 | 22.52% |
| 3 Years | 91.34 | 118.67 | 62.55 | 88.36 | 7,763,943 | 26.62 | 29.14% |
| 5 Years | 64.42 | 125.86 | 55.0623 | 85.95 | 7,065,642 | 53.54 | 83.11% |
AbbVie Description
| AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health. |
